analyzeportfolio
NYSE · Industrials

AMN HEALTHCARE SERVICES INC (AMN)

As-reported financials and SEC filings for AMN HEALTHCARE SERVICES INC. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About AMN HEALTHCARE SERVICES INC

AMN Healthcare Services Inc provides staffing, recruitment, and workforce management solutions for the healthcare industry in the United States. The company offers temporary and permanent placement of healthcare professionals, including nurses, physicians, allied health professionals, and executives, along with technology platforms and consulting services to optimize healthcare workforce management. AMN serves healthcare organizations by helping them build and manage cost-effective, quality workforces across various care delivery settings.

Snapshot

Revenue
$2.73B
Revenue growth (YoY)
-8.5%
Net income
$-95.7M
Diluted EPS
$-2.48
Gross margin
28.3%
Operating margin
-2.0%
Net margin
-3.5%
FCF margin
8.6%
ROE
-14.9%
net income / fiscal-year-end equity
P/E
trailing when available, otherwise FY EPS
Market cap
$1.34B
Long-term debt / equity
1.19×
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Amn Healthcare Services

  • Revenue fell 8.5% to $2.7B in FY2025, after a 21.3% decline the year before.
  • Operating margin is now a 2.0% loss in FY2025, from 12.0% in FY2021.
  • Most recent quarter Q2 FY2026: revenue $673M, up 2.3% from Q2 FY2025.
  • Free cash flow was $234M in FY2025, 8.6% of revenue.
  • Net loss narrowed to $96M in FY2025, from $147M in FY2024.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Amn Healthcare Services’s fundamentals sit among the 684 Industrials companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Gross margin28.3%
51st percentile of 466
Operating margin-2.0%
25th percentile of 605
Net margin-3.5%
22nd percentile of 645
FCF margin8.6%
65th percentile of 562
Revenue growth (YoY)-8.5%
16th percentile of 668
ROE-14.9%
19th percentile of 600
Long-term debt / equity1.19×
82nd percentile of 409
Short interest3.28d
51st percentile of 676

No reported insider purchases (code P) in the last 90 days; 2 insider sales totaling $114,362. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 2 of the superinvestors we track (plus 5 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
2
+5 quant / multi-strat
Initiated / added
3
2 new, 1 added
Reduced / exited
5
4 trimmed, 1 exited
Combined position
$118.6M
reported long value
InvestorAs ofPosition valueSharesChange
Two Sigma InvestmentsquantQ2 2026$37.5M1.2MReduced
Renaissance TechnologiesquantQ2 2026$35.5M1.1MReduced
D. E. ShawquantQ2 2026$17.8M550.6KReduced
AQR Capital ManagementquantQ2 2026$16.3M502.9KAdded
First Eagle Investment ManagementQ2 2026$6.4M196.2KNew
Citadel AdvisorsquantQ2 2026$3.4M103.7KReduced
Gotham Asset ManagementQ2 2026$1.8M54.4KNew

No longer held by: Millennium Management (as of Q2 2026)

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
0
code P
Bought (90d)
code P value
Sells (90d)
2
$114K
Reported activity
Net selling
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-06-15
filed 2026-06-17
FOLETTA MARK GDirectorSell2.0K$31.07$62K
2026-06-15
filed 2026-06-17
FOLETTA MARK GDirectorSell1.7K$31.07$52K

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
3.2M
settled 2026-08-14
Change vs prior
-6.9%
vs previous settlement
Days to cover
3.28
at avg daily volume
Avg daily volume
964.7K
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-143.2M-6.9%3.28
2026-07-313.4M-6.0%5.42
2026-07-153.6M+11.1%3.88
2026-06-303.3M+5.7%2.98
2026-06-153.1M+12.1%3.00
2026-05-292.7M+6.1%2.50
2026-05-152.6M+5.3%1.59
2026-04-302.5M+2.5%3.37

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$2.73B$2.98B$3.79B$5.24B$3.98B
Gross profit$774.1M$919.4M$1.25B$1.72B$1.31B
Operating income$-55.5M$-102.7M$338.4M$647.1M$478.0M
Net income$-95.7M$-147.0M$210.7M$444.1M$327.4M
Diluted EPS$-2.48$-3.85$5.36$9.90$6.81

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$269.5M$320.4M$372.2M$653.7M$305.4M
Capital expenditure$35.6M$80.9M$103.7M$75.8M$53.6M
Free cash flow$233.8M$239.5M$268.5M$577.9M$251.8M

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$673.2M2.3%$21.2M$0.53
Q1 FY2026$1.38B99.9%$62.2M$1.59
Q4 FY2025$748.2M1.8%$-7.7M$-0.20
Q3 FY2025$634.5M-7.7%$29.3M$0.76
Q2 FY2025$658.2M-11.1%$-116.2M$-3.02
Q1 FY2025$689.5M-16.0%$-1.1M$-0.03
Q4 FY2024$734.7M-10.2%$-187.5M$-4.93
Q3 FY2024$687.5M-19.4%$7.0M$0.18

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNYSE
SectorIndustrials
SIC industryServices-Help Supply Services
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ2 FY2026 (ended June 30, 2026)
Oldest indexed filing2010
SEC CIK1142750

Selected SEC filings

10-K2026-02-20
View on EDGAR →
10-Q2026-08-07
View on EDGAR →
10-Q2026-05-08
View on EDGAR →
10-Q2025-11-07
View on EDGAR →
8-K2026-08-06
View on EDGAR →
8-K2026-05-07
View on EDGAR →
8-K2026-05-04
View on EDGAR →
8-K2026-02-19
View on EDGAR →

Largest Industrials peers

All Industrials companies →

Monitor AMN

Get an alert when Amn Healthcare Services files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor AMN free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.